
Weixing chen
Articles
-
Oct 21, 2024 |
tandfonline.com | Ye Zong |Xing LI |Weixing chen |Honghui Chen
AbstractObjective Tegoprazan represents a newly developed potassium-competitive acid blocker utilized for the treatment of acid-related disorders. The present study aimed to explore the therapeutic effectiveness of tegoprazan in Chinese individuals with duodenal ulcers (DU).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →